News Channels

09 Mar 2020 AbbVie Partnering with Global Authorities to Determine Efficacy of HIV Drug in Treating COVID-19
09 Mar 2020 Bristol Myers Squibb Reports Primary Results of ELOQUENT-1 Study Evaluating Empliciti (elotuzumab) Plus Revlimid (lenalidomide) and Dexamethasone in Patients with Newly Diagnosed, Untreated Multiple Myeloma
09 Mar 2020 New report with sales data for recombinant therapeutic antibodies and proteins shows continued success of innovative antibodies
09 Mar 2020 MolMed signs a multi-year agreement and announces the beginning of a new collaboration in the field of T cell therapies
09 Mar 2020 CytoDyn Files IND and Protocol for Phase 2 Clinical Trial for Treatment of Patients with Coronavirus with Leronlimab (PRO 140)
09 Mar 2020 Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets
09 Mar 2020 Zhimeng Biopharma Announces the First-in-Human Dosing in Phase I Clinical Trial of ZM-H1505R Designed for the Treatment of Chronic Hepatitis B Virus Infection
09 Mar 2020 Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement
08 Mar 2020 Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for the Treatment of Cancer and Coronavirus COVID-19
08 Mar 2020 Shionogi and Tetra Therapeutics Entered into New Strategic Collaboration for BPN14770, the Drug Candidates for the Treatment of Brain Disorders Marked by Cognitive and Memory Deficits
08 Mar 2020 FDA Approves New Treatment for Adults with Cushing’s Disease
08 Mar 2020 European Commission Grants AbbVie Marketing Authorization Shortening MAVIRET® (glecaprevir/pibrentasvir) Treatment Duration to Eight Weeks for Treatment-Naïve Chronic HCV Patients with Genotype 3 and Compensated Cirrhosis
08 Mar 2020 Update on Phase III DANUBE trial for Imfinzi and tremelimumab in unresectable, Stage IV bladder cancer
06 Mar 2020 Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets
05 Mar 2020 Dynacure Announces First Patient Dosed in Phase 1 / 2 'UNITE-CNM' Study of DYN101 for the Treatment of Myotubular and Centronuclear Myopathies (CNM)
05 Mar 2020 Heat Biologics Announces Research Collaboration with University of Miami to Develop Vaccine Designed to Protect Against COVID-19 Coronavirus
05 Mar 2020 Debiopharm Advances into the Highly Anticipated Clinical Phase for their Potent WEE1 Inhibitor
05 Mar 2020 BioCryst Begins Proof of Concept Trial in PNH Patients With Oral Factor D Inhibitor, BCX9930
05 Mar 2020 EpiVax Accelerates COVID-19 Vaccine Development with UGA's Center for Vaccines and Immunology
04 Mar 2020 Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine using STARR Technology™

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up